Search Within

Montreh Tavakkoli

Formats
  1. Meeting Abstract (8)
  2. Journal Article (4)
Groups
  1. Adult Leukemia (9)
  2. Center for Hematologic Malignancies (9)
  3. Department of Medicine (9)
  4. Hematologic Malignancies, Division of (9)
  5. Biostatistics Service (2)
  6. Department of Pathology and Laboratory Medicine (2)

More Groups

People
  1. Christopher Park (9)
  2. Stephen Chung (6)
  3. Dong Lee (4)
  4. Benjamin Durham (3)
  5. Daniel Royston (2)
  6. Julie Feldstein (2)

More People

Years
  1. 2018 (1)
  2. 2017 (1)
  3. 2016 (2)
  4. 2015 (5)
  5. 2014 (3)
Publications
  1. Blood (3)
  2. Laboratory Investigation (2)
  3. Modern Pathology (2)
  4. Acta Haematologica (1)
  5. Blood Cancer Journal (1)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Society of Hematology (3)
  2. Nature Publishing Group (3)
  3. Nature Research (2)
  4. American Association for Cancer Research (1)
  5. American Association for the Advancement of Science (1)
  6. Frontiers Media S.A. (1)

More Publishers

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The significance of leukocytosis in malignancies: A novel paradigm between leukocytosis, G-CSF, myeloid-derived suppressor cells and prognosis
    Meeting Abstract

    Tavakkoli, M.; Wilkins, C.; Mones, J. V.; Mauro, M. J.
    Blood (2018)

    Fulltext@MSK | Save
  • CD99 is a therapeutic target on disease stem cells in myeloid malignancies
    Journal Article

    Chung, S. S.; Eng, W. S.; Hu, W.; Khalaj, M.; Garrett-Bakelman, F. E.; Tavakkoli, M.; Levine, R. L.; Carroll, M.; Klimek, V. M.; Melnick, A. M.; more...
    Science Translational Medicine (2017)

    Fulltext@MSK | Save
  • CD164: A novel marker distinguishing hematopoietic stem/progenitor cells (HSPC) from leukemic stem cells
    Meeting Abstract

    Royston, D.; Gao, Q.; Tavakkoli, M.; Chung, S. S.; Devlin, S.; Roshal, M.; Park, C.
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • CD164: A novel marker distinguishing hematopoietic stem/progenitor cells (HSPC) from leukemic stem cells
    Meeting Abstract

    Royston, D.; Gao, Q.; Tavakkoli, M.; Chung, S. S.; Devlin, S.; Roshal, M.; Park, C.
    Laboratory Investigation (2016)

    Fulltext@MSK | Save
  • Targeting CD99 in T-cell neoplasms
    Meeting Abstract

    Tavakkoli, M.; Lee, D. H.; Chung, S. S.; Park, C. Y.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Acute promyelocytic leukemia: Where did we start, where are we now, and the future
    Journal Article

    Coombs, C. C.; Tavakkoli, M.; Tallman, M. S.
    Blood Cancer Journal (2015)

    Fulltext@MSK | Save
  • Targeting CD99 in T-cell neoplasms with monoclonal antibodies
    Meeting Abstract

    Tavakkoli, M.; Lee, D. H.; Durham, B.; Chung, S. S.; Park, C. Y.
    Blood (2015)

    Fulltext@MSK | Save
  • CD99 is a potential therapeutic target in non-Hodgkin lymphoma
    Meeting Abstract

    Tavakkoli, M.; Lee, D.; Durham, B.; Feldstein, J.; Park, C.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • CD99 is a potential therapeutic target in non-Hodgkin lymphoma
    Meeting Abstract

    Tavakkoli, M.; Lee, D.; Durham, B.; Feldstein, J.; Park, C.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • CD99 is a therapeutic target on disease initiating stem cells in acute myeloid leukemia and the myelodysplastic syndromes
    Meeting Abstract

    Chung, S. S.; Tavakkoli, M.; Klimek, V. M.; Park, C. Y.
    Blood (2014)

    Fulltext@MSK | Save